SeQuent–Viyash Merger Receives Stock Exchange Approvals; NCLT Filing Underway
Mumbai- June 02, 2025: Sequent Scientific (SeQuent), a leading player in the global animal health industry, has announced that it has secured approvals from both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) for its proposed merger with Hyderabad-based Viyash Life Sciences (Viyash). The company has now filed for clearance with the […]
Read More